Shanmuga Hospital
Listing performance
Scheduled dates
Tentative timetable — a past date is not confirmation the step completed
Issue details
- IPO date
- 13 Feb 2025 – 17 Feb 2025
- Listing date
- 21 Feb 2025
- Face value
- ₹1 per share
- Issue price
- ₹54 per share
- Lot size
- 2,000 shares
- Issue type
- Fixed Price issue
- Listing at
- BSE
- Total issue size
- ₹20.62 Cr
- Market cap at offer price
- ₹73.51 Cr
- Promoter holding
- 100.00% → 71.95% pre-issue → post-issue
- ISIN
- INE0TD301017
- Registrar
- Integrated Registry Management Services Pvt.Ltd.
- Lead managers
- Finshore Management Services Ltd.
- Registered office
- 51/24, Saradha College Road, Tamil Nadu
Reservation and application size
How the issue is split between investor categories, and what each may bid
| Investor category | Shares | % of net | % of total |
|---|---|---|---|
| Anchor investor · within QIB | 0 | — | — |
| Market maker | 1,92,000 | — | — |
Application size
Minimum 2,000 shares per lot, in multiples, at ₹54
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 2,000 | ₹1,08,000 |
| S-HNI (min) | 2 | 4,000 | ₹2,16,000 |
| S-HNI (max) | 9 | 18,000 | ₹9,72,000 |
| B-HNI (min) | 10 | 20,000 | ₹10,80,000 |
Category limits
| Category | Bid size | Cut-off |
|---|---|---|
| Retail (RII) | Up to ₹2 lakh | Yes |
| Small HNI (sNII) | ₹2 lakh – ₹10 lakh | No |
| Big HNI (bNII) | Above ₹10 lakh | No |
| Employee | Up to ₹5 lakh | Yes |
Bidding at cut-off means accepting the final issue price without naming one. Only retail and employee applicants may do so.
Anchor investors
Institutional allocation placed a day before the issue opens, carved out of the QIB portion and locked in after listing.
Valuation and performance
Valuation at offer price
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS (₹) | 5.37 | 4.75 |
| P/E (×) | 10.06 | 11.37 |
| Price to book (×) | 3.09 | — |
| Market cap | — | ₹73.51 Cr |
Key performance indicators
- Return on net worth
- 30.71%
- ROCE
- 35.89%
- Debt / equity
- 0.53
- PAT margin
- 12.13%
- NAV per share
- ₹17.49
- Price to book
- 3.09
Single period as reported. Year-on-year movement is in the financials table below, where every period is published.
About Shanmuga Hospital
Shanmuga Hospital Limited, formerly incorporated as Shanmuga Hospital Private Limited on June 26, 2020, was converted to a public limited company on June 6, 2024. The company operates a multispecialty hospital with 151 bed capacity in Salem, Tamil Nadu, strategically located at 51/24, Saradha College Road. The hospital has a legacy dating back to 1981 when Dr. Panneerselvam Palaniappan Shanmugam started a hospital as a sole proprietorship. The hospital acquired the business undertaking of Shanmuga Hospital (Partnership Firm) on December 15, 2023 on a slump sale basis. The company is NABH and NABL accredited and provides extensive inpatient and outpatient care across multiple departments including Oncology, Cardiology, General Surgery, Pediatrics, Neurology, and Endocrinology. The hospital generates revenue from both hospital sales & services and hospital medicinal sales through its main hospital, pharmacy, and clinic units.
Company Analysis
from DRHPShanmuga Hospital Limited is a multispecialty hospital in Salem, Tamil Nadu providing comprehensive healthcare services across multiple medical and surgical specialties including oncology, cardiology, and general surgery.
Shanmuga Hospital Limited, formerly incorporated as Shanmuga Hospital Private Limited on June 26, 2020, was converted to a public limited company on June 6, 2024. The company operates a multispecialty hospital with 151 bed capacity in Salem, Tamil Nadu, strategically located at 51/24, Saradha College Road. The hospital has a legacy dating back to 1981 when Dr. Panneerselvam Palaniappan Shanmugam started a hospital as a sole proprietorship. The hospital acquired the business undertaking of Shanmuga Hospital (Partnership Firm) on December 15, 2023 on a slump sale basis. The company is NABH and NABL accredited and provides extensive inpatient and outpatient care across multiple departments including Oncology, Cardiology, General Surgery, Pediatrics, Neurology, and Endocrinology. The hospital generates revenue from both hospital sales & services and hospital medicinal sales through its main hospital, pharmacy, and clinic units.
Objects of the Issue
- Funding Capital Expenditure towards Purchase of additional Medical Equipment ₹1,452.50 lakhs (70.45% of total issue size) p.77
- General Corporate Purposes ₹383.28 lakhs (18.59% of total issue size) p.77
Issue Structure
- Total Issue
- ₹2,061.72 Lakhs
- Fresh Issue
- 38,18,000 Equity Shares of Face Value ₹10/- each for cash at a price of ₹54/- per Equity Share aggregating to ₹2,061.72 Lakhs
- Offer for Sale
- Nil
- Price Band
- ₹54/- per Equity Share (Fixed Price Issue)
- Lot Size
- 2,000 Equity Shares
- Face Value
- ₹10/- per Equity Share
Business Model
The company operates a multispecialty hospital generating revenue primarily from: (1) Hospital Sales & Services - inpatient and outpatient consultation and treatment services, and (2) Hospital Medicinal Sales - pharmacy operations. The hospital is empanelled with insurance companies, TPAs, ESIC, Railway Hospital, ECHS, Airport Authority of India, and FCI to facilitate patient access and revenue generation. The hospital operates with 151 beds across various specialty departments and ancillary units including a diagnostic centre with advanced imaging facilities, pharmacy, and a peripheral clinic.
Business Segments
Promoters
| Name | Role | Pre-Issue | Post-Issue |
|---|---|---|---|
| Panneerselvam Palaniappan Shanmugam | Promoter | 24.81% | 17.85% |
| Prabu Sankar Panneerselvam | Promoter | 24.81% | 17.85% |
| Priyadharshni Dhandapani | Promoter | 24.81% | 17.85% |
| Jayalakshmi Panneerselvam | Promoter | 24.81% | 17.85% |
Leadership
Auto-extracted from the company's DRHP using AI, with each fact linked to its source passage (hover any row to see the quote & page). Provided for research only, not investment advice — verify against the official DRHP before relying on it.